Managers / Q2 2023 · view latest →
CROSSPOINT FINANCIAL, LLC
CIK 0001927769 · 17822 EAST 17TH STREET, SUITE 310, TUSTIN, CA, 92780 · 714-617-4463
Summary
Crosspoint Financial, LLC reported $10M in U.S.-listed holdings across 10 positions for Q2 2023.
The portfolio is heavily concentrated: BRK/B alone accounts for 29.9% of reported value.
Compared with Q1 2023, the fund opened 1 new position and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- ETP · 65.3% · $6M
- Common Stock · 34.7% · $3M
- Equity WRT · 0.0% · $2,050
Quarter-over-Quarter Changes full breakdown →
vs Q1 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ALLOALLOGENE THERAPEUTICS INC | NEW | +12.0K | 12.0K | +$59,640 | $59,640 |
| METAMETA PLATFORMS INC | ADDED | +100 | 1.1K | +$102,613 | $311,374 |
| ETF SER SOLUTIONS | HELD | −840 | 68.6K | +$32,352 | $2M |
| BRK/BBERKSHIRE HATHAWAY INC DEL | HELD | +0 | 8.6K | +$277,334 | $3M |
| IHAKISHARES TR | HELD | +1 | 34.0K | +$50,052 | $1M |
| OIHVANECK ETF TRUST | HELD | +0 | 4.6K | +$48,047 | $1M |
| TERNS PHARMACEUTICALS INC | HELD | +0 | 12.1K | −$37,246 | $105,473 |
| FIRST TR EXCHNG TRADED FD VI | HELD | +0 | 23.1K | +$30,184 | $771,023 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | BRK/BBERKSHIRE HATHAWAY INC DELhistory → | CL B NEW | 29.85% | $3M | 8.6K |
| 2 | ETF SER SOLUTIONS | DEFIANCE NEXT | 23.49% | $2M | 68.6K |
| 3 | OIHVANECK ETF TRUSThistory → | OIL SERVICES ETF | 13.43% | $1M | 4.6K |
| 4 | IHAKISHARES TRhistory → | CYBERSECURITY | 13.10% | $1M | 34.0K |
| 5 | FIRST TR EXCHNG TRADED FD VI | FT CBOE VEST US | 7.84% | $771,023 | 23.1K |
| 6 | IAUISHARES GOLD TRhistory → | ISHARES NEW | 7.42% | $729,331 | 20.0K |
| 7 | METAMETA PLATFORMS INChistory → | CL A | 3.17% | $311,374 | 1.1K |
| 8 | TERNS PHARMACEUTICALS INC | COM | 1.07% | $105,473 | 12.1K |
| 9 | ALLOALLOGENE THERAPEUTICS INC | COM | 0.61% | $59,640 | 12.0K |
| 10 | MICROVAST HOLDINGS INC | *W EXP 04/01/202 | 0.02% | $2,050 | 10.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $40M | 35 | May 13, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $42M | 37 | Feb 5, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $37M | 33 | Aug 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $35M | 30 | May 1, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $29M | 25 | Oct 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $24M | 18 | Jul 26, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $12M | 13 | Apr 24, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $10M | 11 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $9M | 9 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $10M | 10 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $9M | 9 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $9M | 9 | Feb 8, 2023 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.